DIRECT ENANTIOMERIC HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC SEPARATION OF PROPAFENONE AND ITS MAJOR METABOLITE IN SERUM ON A CELLULOSE TRIS-3,5-DIMETHYLPHENYL CARBAMATE CHIRAL STATIONARY PHASE

被引:13
作者
ABOULENEIN, HY
BAKR, SA
机构
[1] Drug Development Laboratory, Radionuclide & Cyclotron Operations Department, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211
关键词
D O I
10.1002/bmc.1130070110
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A direct, isocratic and simple liquid chromatographic method is described for the enantiomeric separation of propafenone (PRO) and its major metabolite, 5-hydroxypropafenone, using a cellulose tris-3,5-dimethylphenyl carbamate (Chiralcel ODS) column. The stereochemical separation factor (alpha) obtained was 1.14 and the maximum stereochemical resolution factor (R) was 0.80 when using a mobile phase consisting of hexane: 2-propanol: diethylamine (90:10:0.4) at 23-degrees-C. The hydroxy metabolite could not be successfully separated into its corresponding enantiomers under these chromatographic conditions. The method has been used to determine and identify the enantiomers of PRO and its hydroxy metabolite in a serum sample.
引用
收藏
页码:38 / 40
页数:3
相关论文
共 19 条
[1]   DIRECT HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC SEPARATION OF PENBUTOLOL ENANTIOMERS ON A CELLULOSE TRIS-3,5-DIMETHYLPHENYL CARBAMATE CHIRAL STATIONARY PHASE [J].
ABOULENEIN, HY ;
ISLAM, MR .
CHIRALITY, 1989, 1 (04) :301-304
[2]  
ABOULENEIN HY, 1990, ANAL LETT, V23, P973
[3]   DIRECT SEPARATION AND OPTIMIZATION OF TIMOLOL ENANTIOMERS ON A CELLULOSE TRIS-3,5-DIMETHYLPHENYLCARBAMATE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC CHIRAL STATIONARY PHASE [J].
ABOULENEIN, HY ;
ISLAM, MR .
JOURNAL OF CHROMATOGRAPHY, 1990, 511 :109-114
[4]   DIRECT HPLC SEPARATION AND OPTIMIZATION OF CELIPROLOL ENANTIOMERS [J].
ABOULENEIN, HY ;
ISLAM, MR .
ANALYTICAL LETTERS, 1990, 23 (01) :83-91
[5]   PROPAFENONE INTERACTS STEREOSELECTIVELY WITH BETA-1-ADRENERGIC AND BETA-2-ADRENERGIC RECEPTORS [J].
BURNETT, DM ;
GAL, J ;
ZAHNISER, NR ;
NIES, AS .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 (05) :615-619
[6]   THE MULTIPLE-MODES OF ACTION OF PROPAFENONE [J].
DUKES, ID ;
WILLIAMS, EMV .
EUROPEAN HEART JOURNAL, 1984, 5 (02) :115-125
[7]   REVERSED-PHASE LC RESOLUTIONS OF CHIRAL ANTIARRHYTHMIC AGENTS VIA DERIVATIZATION WITH HOMOCHIRAL ISOTHIOCYANATES [J].
GAL, J ;
DESAI, DM ;
MEYERLEHNERT, S .
CHIRALITY, 1990, 2 (01) :43-51
[8]   PROPAFENONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN THE TREATMENT OF ARRHYTHMIAS [J].
HARRON, WG ;
BROGDEN, RN .
DRUGS, 1987, 34 (06) :617-647
[9]   THE METABOLIC-FATE OF H-2-LABELED PROPAFENONE IN MAN [J].
HEGE, HG ;
HOLLMANN, M ;
KAUMEIER, S ;
LIETZ, H .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1984, 9 (01) :41-55
[10]   METABOLITE CUMULATION DURING CHRONIC PROPAFENONE DOSING IN ARRHYTHMIA [J].
KATES, RE ;
YEE, YG ;
WINKLE, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (06) :610-614